Unknown

Dataset Information

0

Proteomic Identification of the Galectin-1-Involved Molecular Pathways in Urinary Bladder Urothelial Carcinoma.


ABSTRACT: Among various heterogeneous types of bladder tumors, urothelial carcinoma is the most prevalent lesion. Some of the urinary bladder urothelial carcinomas (UBUCs) develop local recurrence and may cause distal invasion. Galectin-1 de-regulation significantly affects cell transformation, cell proliferation, angiogenesis, and cell invasiveness. In continuation of our previous investigation on the role of galectin-1 in UBUC tumorigenesis, in this study, proteomics strategies were implemented in order to find more galectin-1-associated signaling pathways. The results of this study showed that galectin-1 knockdown could induce 15 down-regulated proteins and two up-regulated proteins in T24 cells. These de-regulated proteins might participate in lipid/amino acid/energy metabolism, cytoskeleton, cell proliferation, cell-cell interaction, cell apoptosis, metastasis, and protein degradation. The aforementioned dys-regulated proteins were confirmed by western immunoblotting. Proteomics results were further translated to prognostic markers by analyses of biopsy samples. Results of cohort studies demonstrated that over-expressions of glutamine synthetase, alcohol dehydrogenase (NADP?), fatty acid binding protein 4, and toll interacting protein in clinical specimens were all significantly associated with galectin-1 up-regulation. Univariate analyses showed that de-regulations of glutamine synthetase and fatty acid binding protein 4 in clinical samples were respectively linked to disease-specific survival and metastasis-free survival.

SUBMITTER: Li CF 

PROVIDER: S-EPMC5979315 | BioStudies | 2018-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC5084672 | BioStudies
2020-01-01 | S-EPMC7456169 | BioStudies
2016-01-01 | S-EPMC4749368 | BioStudies
2018-01-01 | S-EPMC6301801 | BioStudies
1000-01-01 | S-EPMC4747885 | BioStudies
2020-01-01 | S-EPMC6929993 | BioStudies
1000-01-01 | S-EPMC4632072 | BioStudies
2016-01-01 | S-EPMC4829558 | BioStudies
2020-01-01 | S-EPMC7098797 | BioStudies
2017-01-01 | S-EPMC5785709 | BioStudies